Pancreatic Cancer Research

ResearcherShanghai UniversityActive in the last 2 years

Fan Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1044-7821; OpenAlex author ID A5024572557. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 4 papers

Papers 6

  1. HIF-3α Facilitates the Proliferation and Migration in Pancreatic Cancer by Inhibiting Autophagy Through Downregulating TP53INP2. Co-author DOI 10.1007/s12013-024-01624-y↗
  2. Establishment of a prognostic model for pancreatic cancer based on vesicle-mediated transport protein-related genes. Co-author DOI 10.1080/10255842.2024.2367739↗
  3. ITGB4/BNIP3 Activates Autophagy and Reduces MHC-I Expression to Mediate Tumour Immune Escape in Pancreatic Cancer Cell Lines. First author DOI 10.1111/imm.13890↗
  4. MEF2A, MEF2C, and MEF2D as potential biomarkers of pancreatic cancer? Co-author DOI 10.1186/s12885-025-14107-x↗
  5. Construction and validation of a pancreatic cancer prognostic model based on genes related to the hypoxic tumor microenvironment. Co-author DOI 10.3748/wjg.v30.i36.4057↗
  6. LncRNA TUG1 promoted viability and associated with gemcitabine resistant in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.jphs.2018.06.002↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xianfei Zhou · 3 shared papers, 2025 · strength 0.91
  2. Renwei Xing · 2 shared papers, 2025 · strength 0.61
  3. Yanfang Cao · 1 shared paper, 2025 · strength 0.33
  4. Yong Lan · 1 shared paper, 2025 · strength 0.30
  5. Hanqiu Nie · 1 shared paper, 2025 · strength 0.28
  6. Chun-Xia Zhai · 1 shared paper, 2025 · strength 0.28
  7. Yi Ding · 1 shared paper, 2025 · strength 0.28
  8. Yingjie Guo · 1 shared paper, 2024 · strength 0.26
  9. Xiuling Li · 1 shared paper, 2018 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.